CareDx - 10 Year Stock Price History | CDNA
- The all-time high CareDx stock closing price was 95.60 on January 20, 2021.
- The CareDx 52-week high stock price is 12.93, which is 71% above the current share price.
- The CareDx 52-week low stock price is 4.80, which is 36.5% below the current share price.
- The average CareDx stock price for the last 52 weeks is 8.96.
CareDx Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 9.7378 | 11.9400 | 12.3700 | 7.5600 | 7.5600 | -37.00% |
2023 | 9.6327 | 11.1000 | 17.6100 | 4.9000 | 12.0000 | 5.17% |
2022 | 25.6693 | 46.6000 | 46.6000 | 10.8800 | 11.4100 | -74.91% |
2021 | 71.2634 | 71.4900 | 95.6000 | 41.2000 | 45.4800 | -37.23% |
2020 | 35.7752 | 21.1500 | 77.0900 | 13.9400 | 72.4500 | 235.88% |
2019 | 27.9135 | 23.9800 | 40.0800 | 19.2400 | 21.5700 | -14.20% |
2018 | 15.5675 | 7.0500 | 30.0200 | 5.1800 | 25.1400 | 242.51% |
2017 | 2.9090 | 2.3000 | 7.3700 | 0.7857 | 7.3400 | 171.85% |
2016 | 4.4480 | 6.2700 | 6.3300 | 2.6500 | 2.7000 | -57.81% |
2015 | 6.0152 | 7.2250 | 7.6700 | 4.1100 | 6.4000 | -11.72% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.413B | $0.280B |
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.048B | 15.56 |
Cencora (COR) | United States | $47.467B | 18.94 |
ICON (ICLR) | Ireland | $25.527B | 24.10 |
DiDi Global (DIDIY) | China | $23.901B | 0.00 |
Avantor (AVTR) | United States | $17.269B | 23.79 |
Viatris (VTRS) | United States | $13.856B | 3.96 |
CochLear (CHEOY) | $13.551B | 0.00 | |
Revvity (RVTY) | United States | $12.684B | 22.08 |
Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
Natera (NTRA) | United States | $11.049B | 0.00 |
Solventum (SOLV) | United States | $10.961B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.795B | 50.77 |
Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
Organon (OGN) | United States | $4.783B | 4.63 |
Doximity (DOCS) | United States | $4.461B | 33.21 |
PACS (PACS) | United States | $3.596B | 0.00 |
Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Progyny (PGNY) | United States | $3.133B | 52.58 |
Life Times (LTH) | United States | $2.882B | 31.85 |
GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
Premier (PINC) | United States | $2.531B | 9.26 |
Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
Agilon Health (AGL) | United States | $2.191B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.328B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
Embecta (EMBC) | United States | $0.627B | 4.14 |
Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
Enhabit (EHAB) | United States | $0.510B | 46.23 |
COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
LifeMD (LFMD) | United States | $0.450B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
Beauty Health (SKIN) | United States | $0.389B | 0.00 |
MultiPlan (MPLN) | United States | $0.375B | 0.00 |
DocGo (DCGO) | United States | $0.367B | 58.67 |
ModivCare (MODV) | United States | $0.353B | 4.68 |
Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
Sharecare (SHCR) | United States | $0.277B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.121B | 40.67 |
Oncology Institute (TOI) | United States | $0.089B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |